Metabotropic Glutamate Receptor 6 (GRM6) (NM_000843) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC221195L4V
- LentiORF®
Lenti ORF particles, GRM6 (mGFP-tagged) - Human glutamate receptor, metabotropic 6 (GRM6), 200ul, >10^7 TU/mL
Lentiviral Particles: DDK w/ Puro
Product Images
Frequently bought together (3)
Other products for "Metabotropic Glutamate Receptor 6"
Specifications
Product Data | |
Type | Human Tagged ORF Clone Lentiviral Particle |
Tag | mGFP |
Symbol | Metabotropic Glutamate Receptor 6 |
Synonyms | CSNB1B; GPRC1F; mGlu6; MGLUR6 |
Mammalian Cell Selection | Puromycin |
Vector | pLenti-C-mGFP-P2A-Puro |
ACCN | NM_000843 |
ORF Size | 2631 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC221195).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_000843.2 |
RefSeq Size | 6122 bp |
RefSeq ORF | 2634 bp |
Locus ID | 2916 |
UniProt ID | O15303 |
Cytogenetics | 5q35.3 |
Protein Families | Druggable Genome, Transmembrane |
Protein Pathways | Neuroactive ligand-receptor interaction |
MW | 95.3 kDa |
Gene Summary | L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.